Federal Awards

Badawy, Mohamed, Med Coll. of Wisconsin/NIH, Use of Mechanism of Injury for the Identification of Severely Injured Children, $102,473; Cleaver, Ondine, NIH, GTPases as Molecular Gatekeepers of Cytoskeletal and Cellular Polarization, $384,295; Danuser, Gaudenz, NIH, Mechanochemical Regulation of Actin-Mediated Cell Protrusion, $324,000; Deberardinis, Ralph, St. Jude Children’s Res Hosp./NIH, Regulation of Erythropoiesis by the miR-144/451 microRNA locus, $76,370; D'Orso, Ivan, NIH, Functional Interplay Between Tat and Novel Host Co-Factors in HIV Transcription, $393,837; Fu, Yang-Xin, Univ of NC Chapel Hill/NIH, Novel Therapeutic Approaches to Treating Chronic Hepatitis B Virus Infection, $167,431; Garg, Abhimanyu, NIH, Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients, $328,050; Green, Carla (Fellow C. Rosenweig), NIH, Investigation of the Spontaneous Circadian Hamster Mutation Theta, $30,812;

Haley, Robert, Dept of Defense, GWI Blood Test, $372,574; Hansen, Eric, NIH, Multiple Effectors of Autoprocessed Haemophilus Ducreyi Virulence Factor, $243,000; Hsia, Connie, NIH, Structural Plasticity in Compensatory Lung Growth and Remodeling, $705,707; Huber, Kimberly, Emory Univ/NIH, FMRP Mechanism and Function, $63,558; Kittler, Ralf, NIH, Development of Small Molecules for ERG Ablation in Prostate Cancer, $333,517; Konopka, Genevieve, NIH, Functional Dissection of Mammalian Vocal Communication, $309,825; Kraus, William (Fellow D. Kim), Dept of Defense, Functional Interplay Between PARP-1 and Long Noncoding RNAs in Breast Cancer, $108,000; Liou, Jen, NIH, Functions and Regulation of Endoplasmic Reticulum-Plasma Membrane Junctions, $284,904; Lotan, Yair, Natl Science Fdn., Functionalized Nano-Textured Surfaces to Isolate and Identify Tumor Cells, $50,751;

Luo, Weibo, NIH, The Role of JMJD2C in HIF-1 Activation and Breast Cancer Progression, $249,000; Malloy, Craig, Duke Univ/NIH, Development of Novel Therapies for NIDDM-P4, $116,947; Meeks, Julian, NIH, Inhibitory Processing and Social Learning in the Accessory Olfactory Bulb, $340,849; Mendelson, Carole, NIH, Mechanisms in the Biology of Pregnancy and Parturition, $1,343,013; Miles, Darryl, Univ of Wisconsin/NIH, Magnetic Resonance Imaging (MRI) Markers of Outcome after Severe Pediatric Traumatic Brian Injury (TBI), $14,000; Mitchell, Ron, Children’s Hosp. Philadelphia/NIH, Impact of Mild Sleep-Disordered Breathing on Children’s Health, $74,610; Morrison, Sean (Fellow M. Murphy), NIH, Neural Regulation of the Hematopoietic Stem Cell Niche, $58,002; Mukhopadhyay, Saikat, NIH, Signaling at the Primary Cilium in Development and Disease, $249,318;

Niederkorn, Jerry, NIH, Immunological Modulation of Ocular Tumor Metastases, $253,953; Nijhawan, Ank, NIH, Reducing Readmissions and Improving Outcomes in HIV-Infected Patients, $178,169; Olson, Eric, NIH, Deciphering the Role of a Novel Micropeptide in Cardiac Function and Dysfunction, $566,796; Olson, Eric (Fellow K. Carroll), NIH, Role of the Myocardin-Related Transcription Factors in Cardiac Development, $57,066; Pasare, Chandrashekhar, NIH, Innate Mechanisms of Regulation of Memory Th17 Cell Responses, $405,000; Powell, Craig (Fellow H. Speed), Dept of Defense, Preclinical Treatment of an Organophosphate Model of Gulf War Illness, $183,079; Raskin, Philip, George Washington Univ/NIH, Glycemia Reduction Approaches in Diabetes, $143,289; Saxena, Ramesh, Univ of Washington/NIH, Biological Determinants of Peritoneal Dialysis Outcomes, $1; Scherer, Philipp, Maine Med Ctr Res Inst/NIH, Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism and Energy Balance, $32,027; Schneider, Jay, Univ of Maryland/NIH, Nuclear Dynamics: A New Frontier of hPSC-Cardiomyocyte Biology, $50,000;

Sherry, Dean, NIH, PARACEST Agents for Molecular Imaging of Cancer by MRI, $307,800; Singal, Amit, Georgetown Univ/NIH, Glycans in Hepatocellular Carcinoma, $34,650; Slone, Tamra, Children’s Hosp. Philadelphia/NIH, BIQSFP-COG AALL1131 Supplemental Funds, $18,674; Sperandio, Vanessa, NIH, Tryptophan Derivatives in EHEC Pathogenesis, $458,512; Sun, Xiankai, UT Arlington/NIH, Radiotherapeutic Nanoseeds for Internal Radiation Therapy, $41,045; Terman, Jonathan, NIH, Molecular Mechanisms of Axon Guidance and Neural Connectivity, $357,750; Towler, Dwight, Georgia Regents Univ/NIH, Wnt/G3BP1 Signaling In Arterial Calcification: Mitigation by PADI Inhibition, $99,491; Unger, Roger, REMD Biotherapeutics/NIH, Assessment of the Glucagon Receptor Blocker REMD-477 on Insulin Requirements in Type 1 Diabetes, $1; Winter, Sebastian, NIH, Lactate Metabolism During Salmonella Infection, $202,500.

Non-Federal Awards

Akbay, Esra, Intl Assoc for Study of Lung Cancer, Overcoming Resistance to EGFR Inhibition Through Immunotherapy, $30,000; Banaszynski, Laura, CPRIT, Recruitment Award, $489,188; Beutler, Bruce (Fellow K. Tabeta), Niigata Univ, Niigata Univ Research Support Allowance, $40,000; Bruick, Richard, CPRIT, Discovery and Optimization of Natural and Artificial Ligands Regulating Hypoxia Inducible Factor, $486,842; Conrad, Nicholas, RNA Society, The RNA Society Sponsorship of RNA Salon Activities, $1,000; Cullum, Munro, TX Council on Alzheimer’s Disease & Rel DS, FY17 TARCC External Advisory Committee, $205,693; Ge, Wuping, Amer Heart Assoc, Investigation of the Role of Smooth-Muscle Cells in Ischemia with Magnetic Force, $75,000; Hooper, Lora (Fellow T. Harris-Tryon), Burroughs Wellcome Fund, Microbiota-Immune System Interactions in the Skin, $20,000;

McCulley, James, Research to Prevent Blindness, Research to Prevent Blindness Unrestricted Grant, $115,000; Mukhopadhyay, Saikat, Alex’s Lemonade Stand, Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation, $200,000; Nijhawan, Deepak, Welch Fdn., Expanding the Druggable Genome, $65,000; Olson, Eric (Fellow L. Amoasii), Amer Diabetes Assoc, Molecular Mechanism that Mimics Exercise and Resists Metabolic Syndrome, $57,244; Pandya, Amit, Henry Ford Health Systems, Vitiligo Biobank Specimen Registry, $27,000; Quiceno, Mary, Amer Coll. of Radiology, Imaging Dementia - Evidence for Amyloid Scanning (IDEAS), $18,750; Scaglioni, Pier, CPRIT, Mutant KRAS Reprograms Lipid Metabolism Exposing Beta-Oxidation as a Novel Therapeutic Target in Lung Cancer, $231,124; Thomas, Philip, US-Israel Binatl Science Fdn., Discovery and Mode of Action Studies of CFTR Modulators Acting on NBD1, $22,357;

Trivedi, Madhukar, CPRIT, Promoting Activity in Cancer Survivors (PACES), $469,650; Tsai, Peter, Tuberous Sclerosis Alliance, Cerebellar-Cortical Circuits in Tuberous Sclerosis Associated Autism, $75,000; Walsh, Jennifer, TX Higher Education Coord Board, State of Texas GME Expansion Grant, $300,000; Wang, Zhao, Amer Heart Assoc, Pathological Cardiac Remodeling: Role of De No Pyrimidine Synthesis, $75,000.

Industry Sponsored Awards, dollar amounts not available

Aquino, Victor, Mesoblast Sarl, Safety Follow-Up Through 180 Days of Treatment; Bartolome, Sonja, Reata Pharma, Study of Bardoxolone Methyl for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension; Beutler, Bruce, Pfizer, Novel Pathways Mediating Glucose Uptake into Skeletal Muscle; Brown, Elizabeth, Bristol-Myers Squibb, Phase 2 Study of IV Abatacept for Treatment Resistant Nephrotic Syndrome; Brown, Elizabeth, Retrophin, Study of RE-021 for Focal Segmental Glomerulosclerosis; Courtney, Kevin, Merck Sharp & Dohme, Phase 2 Trial of Pembrolizumab for Metastatic Castration-Resistant Prostate Cancer; Farr, Deborah, 3M Pharma, Tegaderm CHG Port Dressing Patient and Clinician Satisfaction Study; Gao, Jinming, OncoNano Medicine, Evaluation of OncoNano Clinical Candidate Probes;

Khan, Saad, Merck Sharp & Dohme, Phase 2 Trial of Pembrolizumab for Thyroid Cancer; MacConmara, Malcolm, Bristol-Myers Squibb, Evaluation of Maintenance Renal Transplant Recipients; Nguyen,Trung Phuoc, Axovant Sciences, Phase 2b Study of RVT-101 for Dementia with Lewy Bodies; Pan, Edward, Vascular Biogenics, Phase 3 Study of VB-111 with Bevacizumab vs. Bevacizumab Monotherapy; Phillips, Margaret, Medicines for Malaria Venture, Development of PD Biomarker to Assess Toxicity of DSM265; Posner, Bruce, Pfizer, Hypothesis Generation for Pfizer 8K Mechanistic Subset; Saxena, Ramesh, Ohio State U, Phase 4 Study of Acthar Gel for Membranous Lupus Nephritis; Trivedi, Madhukar, Janssen Res & Dev, Study of Intranasal Esketamine in Treatment-Resistant Depression.